Introduction: Non-traumatic back pain constitutes roughly 5% of the admissions to emergency departments. This study seeks to compare the efficacy of intravenously administered paracetamol, dexketoprofen, and ibuprofen in patients with non-traumatic acute low back pain.
Methods: This study was designed as a randomized, double-blinded investigation and carried out at a tertiary hospital. 210 eligible patients without trauma who presented with low back pain were recruited for the study and randomized into paracetamol (n = 71), dexketoprofen (n = 70), and ibuprofen (n = 69) groups. The measurements at 0, 15, 30 and 60 min were noted down by using a 100 mm VAS, and the relevant comparisons were made.
Results: The VAS scores at 0 and 60 min in the paracetamol, dexketoprofen, and ibuprofen groups decreased on average by 40 mm, 42 mm, and 43 mm, respectively. The baseline and final pain scores of each drug group differed significantly (p < 0.05), though the between-group analysis revealed no significant difference (p > 0.05).
Conclusion: Given the obtained data, we did not note a significant difference between intravenous paracetamol, dexketoprofen and ibuprofen with respect to pain efficacy in non-traumatic acute low back pain. Based on the patients' clinical conditions and histories, we concluded that the choice of medication might not change the efficacy of the treatment and patient comfort.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajem.2022.04.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Choice of Anti-Inflammatory Influences the Elimination of Protein-Bound Uremic Toxins.
Toxins (Basel)
December 2024
Nephrology and Renal Transplantation, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Pain is a frequent and disturbing symptom among hemodialysis patients. Protein-bound uremic toxins (PBUTs) are related to cardiovascular and overall mortality, and they are difficult to remove with current hemodialysis treatments. The PBUT displacers, such as furosemide, tryptophan, or ibuprofen, may be promising new strategies for improving their clearance.
View Article and Find Full Text PDFA sustainable and green HPLC-PDA technique for the simultaneous estimation of Post-COVID-19 syndrome co-administered drugs with greenness and whiteness assessment.
Sci Rep
October 2024
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, ET-11562, Egypt.
Article Synopsis
- - COVID-19 has emerged as a significant global health issue, with about 10-15% of infected individuals experiencing post-COVID-19 syndrome that can result in ongoing symptoms like fatigue, breathlessness, and cognitive issues that may impact their quality of life.
- - To address these symptoms, treatments like Paracetamol and Dexketoprofen Trometamol are used for pain relief, while Rivaroxaban is prescribed to prevent blood clots for several weeks post-discharge.
- - A new eco-friendly method, utilizing HPLC-DAD technology, was developed to simultaneously measure these medications, showing effective and reliable results for both bulk and plasma samples according to international standards.
Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients.
Life (Basel)
July 2024
Department of Medicine, Toxicology and Dermatology, Faculty of Medicine, University of Valladolid, 47002 Valladolid, Spain.
To describe the need and effectiveness of acute and preventive medications in a series of 100 consecutive patients referred due to COVID-19-related headaches. Patients were aged 48.0 (standard deviation (SD): 12.
View Article and Find Full Text PDFUnused, expired pharmaceuticals and their disposal practices among the general public in Burdur-Türkiye: a cross-sectional study.
BMC Public Health
May 2024
Mehmet Akif Ersoy University, Health Science Faculty, Burdur, Türkiye.
Background: Unused pharmaceuticals are currently a public health problem. This study aimed to identify unused pharmaceuticals, research practices about the disposal methods, classify the medicines according to Anatomical Therapeutic Chemical codes (ATC) and, to determine the number of unused medicines.
Methods: The study was designed as a cross-sectional study.
Tramadol-paracetamol for postoperative pain after spine surgery - A randomized, double-blind, placebo-controlled study.
Scand J Pain
January 2024
Department of Anaesthesiology and Intensive care, Kuopio University Hospital, PO Box 100, FI-70029 KYS, Kuopio, Finland.
Objectives: Multimodal pain management is one component in enhanced recovery after surgery protocol. Here we evaluate the efficacy of tramadol-paracetamol in acute postoperative pain and pain outcome at 12 months after spine surgery in randomized, double-blind, placebo-controlled trial.
Methods: We randomized 120 patients undergoing spine surgery to receive, for add-on pain management, two tramadol-paracetamol 37.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!